APOPHARM LLC TRADE DATA ANALYSIS
Access comprehensive trade data for Apopharm Llc with ease. Explore trade shipments, top suppliers & buyers, and values without the hassle.
Apopharm Llc – Overview
Eximpedia analyzes Apopharm Llc export and import records, including data from 0 buyers and 6 suppliers. We provide an intelligence report of Apopharm Llc that covers trade statistics, shipment values, quantities, exporters & importers and trade destinations
Apopharm Llc Buyers, Suppliers & Shipments
Apopharm Llc import markets
Explore the Apopharm Llc import market with monthly import values, major importers, HS Codes, key ports, top suppliers, and competitors
TOP IMPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 3002150000 | 6.34 | 8 | 6.45 |
| HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
| 3004390000 | 1.97 | 30 | 24.19 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004900000 | 1.17 | 65 | 52.42 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3002419000 | 0.66 | 7 | 5.65 |
| HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
| 3006109000 | 0.19 | 4 | 3.23 |
| PHARMACEUTICAL GOODS SPECIFIED IN NOTE 4 TO THIS CHAPTER | |||
TOP IMPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| IRELAND | 6.46 | 11 | 8.87 |
| GERMANY | 2.03 | 44 | 35.48 |
| UNITED STATES | 0.69 | 8 | 6.45 |
| FINLAND | 0.56 | 28 | 22.58 |
| BELGIUM | 0.35 | 19 | 15.32 |
TOP IMPORT PORTS
| PORT NAME | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| UA100200 | 5.62 | 93 | 75.00 |
| UA100100 | 4.75 | 31 | 25.00 |
TOP IMPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| ASTRAZENECA PHARMACEUTICALS LLC | 253.12 | 526 |
| JSC R FARM | 346.89 | 560 |
| CJSC ROCH MOSCOW | 381.03 | 196 |
| LLC NAUKA MEDICINE VETERINARY | 43464.58 | 134 |
| TOV ALSI LTDKYIV | 248396.75 | 5287 |
TOP IMPORT SUPPLIERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| CELLSYSTEMS GMBH | 3116.18 | 2 |
| MY BIOTECH SRO | 40348.40 | 20 |
| WALTER FRIES TRADE AND TRANSPORT | 100422.83 | 1803 |
| TH GEYER GMBH AND CO KG | 117078.48 | 3096 |
If you are looking to establish relationship with Apopharm Llc Automation you can save time by getting access to the key decision makers and get a detailed report.
Apopharm Llc Import Shipments
Discover the Apopharm Llc with product description, import values, quantities, exporter name, country of origin and key destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 3002150000 | 1. MEDICINAL PRODUCT FOR HUMANS IN A DOSAGE FORM, BASED ON AN IMMUNOLOGICAL ACTIVE SUBSTANCE. KITRUDA«, CONCENTRATE FOR SOLUTION FOR INFUSIONS, 25 MG/ML, 4 ML OF CONCENTRATE IN A BOTTLE, 1 BOTTLE WITH THE DRUG IN A CARDBOARD BOX WITH LABELING IN UKRAINIAN, SERIES W039486 - 100 CARDS. K-K ACTIVE SUBSTANCE - 1 ML OF CONCENTRATE CONTAINS PEMBROLIZUMAB 25 MG. PEMBROLIZUMAB (CAS 1374853-91-4) IS A HIGHLY SELECTIVE HUMANIZED MONOCLONAL ANTIBODY OF THE IGG4-KAPPA ISOTYPE - A TYPE OF BLOOD GLOBULIN. FOR THERAPEUTIC USE. MARKING IN ACCORDANCE WITH THE LAW OF UKRAINE ""ON MEDICINAL PRODUCTS"". MANUFACTURERS: MSD IRELAND (CARLOW), IRELAND - MANUFACTURER OF BULK PRODUCTS, QUALITY CONTROL AND STABILITY TESTING, PRIMARY PACKAGING; MERCK SHARP AND DOME B.V., THE NETHERLANDS - SECONDARY PACKAGING AND MARKING, PERMISSION TO ISSUE A SERIES.""" |  |
|
IRELAND | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCT FOR HUMANS, PACKAGED FOR RETAIL SALE. TEMODAL«, 100 MG CAPSULES, 1 CAPSULE IN A SACHET, 5 SACHETS IN A CARDBOARD BOX WITH LABELING IN UKRAINIAN, SERIES W030261 - 100 CARDS. K-K ACTIVE SUBSTANCE - 1 CAPSULE CONTAINS 100 MG OF TEMOZOLOMIDE (CAS - 85622-93-1. FOR THERAPEUTIC USE. DOES NOT CONTAIN VITAMINS, IODINE, ANTIBIOTICS, HORMONES, ALKALOIDS. LABELING IN ACCORDANCE WITH ZU ""ON MEDICINAL PRODUCTS"". MANUFACTURERS :- PRODUCTION OF UNPACKAGED PRODUCTS, PRIMARY PACKAGING AND QUALITY CONTROL - ORION PHARMA, FINLAND. - PRIMARY AND SECONDARY PACKAGING, APPROVAL FOR SERIES PRODUCTION - SCHERING-PLAU LABO N.V., BELGIUM.""" | |
|
FINLAND | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCT FOR HUMANS PACKAGED FOR RETAIL SALE. UROMITEXAN« 400 MG, SOLUTION FOR INJECTION, 100 MG/ML, 4 ML (400 MG) IN AN AMPOULE, 5 AMPOULES IN A CONTOUR BLISTER PACK, 3 CONTOUR BLISTER PACKS IN A CARDBOARD BOX LABELED IN UKRAINIAN, SERIES 3C728A - 2250 AMPOULES (150 CARDS). ACTIVE SUBSTANCE - 1 ML OF SOLUTION CONTAINS MESNA 100 MG. FOR THERAPEUTIC USE, DOES NOT CONTAIN VITAMINS (IN THERAPEUTIC QUANTITIES), IODINE , ANTIBIOTICS, HORMONES, ALKALOIDS. LABELING IN ACCORDANCE WITH THE LAW OF UKRAINE ""ON MEDICINAL PRODUCTS"". MANUFACTURER - BAXTER ONCOLOGY GMBH, GERMANY. COUNTRY OF MANUFACTURE - DE. TRADE MARK - BAXTER.""" | |
|
GERMANY | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCT FOR HUMANS - SOLUTION FOR PARENTERAL NUTRITION. NUMETA G16E, EMULSION FOR INFUSIONS, 500 ML EACH (50% GLUCOSE SOLUTION - 155 ML, 5.9% SOLUTION OF AMINO ACIDS WITH ELECTROLYTES - 221 ML; 12.5% LIPID EMULSION - 124 ML) IN A THREE-CHAMBER PLASTIC BAG. THE THREE-CHAMBER PLASTIC BAG IS PACKED IN A PROTECTIVE FILM SHELL CONTAINING AN OXYGEN ABSORBER AND AN OXYGEN INDICATOR; 6 PACKAGES IN A CARDBOARD BOX WITH MARKINGS IN UKRAINIAN AND ENGLISH, SERIES 23F12N42 - 60 THREE-CHAMBER LAYERS. PACKS (10 CARDS, 6 PACKS EACH). ACTIVE SUBSTANCES - 1 PACKAGE OF 500 ML CONTAINS: L-ALANINE - 4.66 G/L; L-ARGININE - 4.89 G/L; L-ASPARTIC ACID - 3.50 G/L; L-CYSTEINE - 1.10 G/L; L-GLUTAMIC ACID - 5.83 G/L; GLYCINE - 2.33 G/L; L-HISTIDINE - 2.21 G/L; L-ISOLEUCINE - 3.90 G/L; L-LEUCINE - 5.83 G/L; L-LYSINE MONOHYDRATE - 7.20 G/L (WHICH IS EQUIVALENT TO LYSINE - 6.41 G/L); L-METHIONINE - 1.40 G/L; L-ORNITHINE HYDROCHLORIDE - 1.85 G/L (WHICH IS EQUIVALENT TO ORNITHINE - 1.45 G/L); L-PHENYLALANINE | |
|
BELGIUM | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCT FOR HUMANS PACKAGED FOR RETAIL SALE. HOLOKSAN« 1 G, POWDER FOR SOLUTION FOR INJECTION 1 G, 1 VIAL WITH POWDER IN A CARDBOARD BOX WITH LABELING IN UKRAINIAN, SERIES 2E157D - 150 CARDS. K-K. ACTIVE SUBSTANCE - 1 BOTTLE CONTAINS IFOSFAMIDE 1 G. FOR THERAPEUTIC USE, DOES NOT CONTAIN VITAMINS (IN THERAPEUTIC QUANTITIES), IODINE, ANTIBIOTICS, HORMONES, ALKALOIDS. LABELING IN ACCORDANCE WITH THE LAW OF UKRAINE ""ON MEDICINAL PRODUCTS"" .MANUFACTURER - BAXTER ONCOLOGY GMBH, GERMANY.""" | |
|
GERMANY | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCT FOR HUMANS - SOLUTION FOR PARENTERAL NUTRITION. NUMETA G13E, EMULSION FOR INFUSIONS, 300 ML EACH (50% GLUCOSE SOLUTION - 80 ML; 5.9% SOLUTION OF AMINO ACIDS WITH ELECTROLYTES - 160 ML; 12.5% LIPID EMULSION - 60 ML) IN A THREE-CHAMBER PLASTIC BAG. THE THREE-CHAMBER PLASTIC BAG IS PACKED IN A PROTECTIVE FILM SHELL CONTAINING AN OXYGEN ABSORBER AND AN OXYGEN INDICATOR; 10 PACKAGES IN A CARDBOARD BOX WITH MARKING IN UKRAINIAN, SERIES 23F12N45 - 100 THREE-CHAMBER LAYERS. PACKAGES (10 CARDS, EACH WITH 10 PACKAGES). ACTIVE SUBSTANCES - 1 PACKAGE WITH A VOLUME OF 300 ML CONTAINS: L-ALANINE - 4.66 G/L; L-ARGININE - 4.89 G/L; L-ASPARTIC ACID - 3.50 G/L; L-CYSTEINE - 1.10 G/L; L-GLUTAMIC ACID - 5.83 G/L; GLYCINE - 2.33 G/L; L-HISTIDINE - 2.21 G/L; L-ISOLEUCINE - 3.90 G/L; L-LEUCINE - 5.83 G/L; L-LYSINE MONOHYDRATE - 7.20 G/L (WHICH IS EQUIVALENT TO LYSINE - 6.41 G/L); L-METHIONINE - 1.40 G/L; L-ORNITHINE HYDROCHLORIDE - 1.85 G/L (WHICH IS EQUIVALENT TO ORNITHINE - 1.45 G/L); L-PHENYLALANINE - 2.45 G/L; L-ABOUT | |
|
BELGIUM | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCT FOR HUMANS - SOLUTION FOR PARENTERAL NUTRITION. OLIMEL N9E, EMULSION FOR INFUSIONS, 1500 ML EACH IN A THREE-CHAMBER PLASTIC BAG IN A PROTECTIVE SHELL CONTAINING AN OXYGEN ABSORBER; 4 PACKAGES IN A CARDBOARD BOX, SERIES 23E30N23 - 60 THREE-CHAMBER LAYERS. BAGS (15 CARDS, 4 BAGS EACH). ACTIVE SUBSTANCES - 1 THREE-CHAMBER BAG OF 1500 ML CONTAINS: 27.5% GLUCOSE SOLUTION WITH CALCIUM - 600 ML; 14.2% SOLUTION OF AMINO ACIDS WITH ELECTROLYTES - 600 ML; 20% LIPID EMULSION - 300 ML. THE COMPOSITION OF THE EMULSION AFTER MIXING THE CONTENTS OF 3 CHAMBERS - 1 BAG OF 1500 ML CONTAINS: ALANINE - 12.36 G; ARGININE - 8.37 G; ASPARTIC ACID - 2.47 G; GLUTAMIC ACID - 4.27 G; GLYCINE - 5.92 G; HISTIDINE - 5.09 G; ISOLEUCINE - 4.27 G; LEUCINE - 5.92 G; LYSINE ACETATE - 9.48 G (WHICH IS EQUIVALENT TO LYSINE - 6.72 G); METHIONINE - 4.27 G; PHENYLALANINE - 5.92 G; PROLINE - 5.09 G; SERINE - 3.37 G; THREONINE - 4.27 G; TRYPTOPHAN - 1.42 G; TYROSINE - 0.22 G; VALINE - 5.47 G; SODIUM ACETATE TRIHYDRATE - 2.24 G; POTASSIUM CHLORIDE - 3.3 | |
|
BELGIUM | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCT FOR HUMANS PACKAGED FOR RETAIL SALE. SIMDAKS, CONCENTRATE FOR PREPARATION OF SOLUTION FOR INFUSIONS, 2.5 MG/ML, 5 ML IN A BOTTLE, 1 BOTTLE IN A CARDBOARD BOX, SERIES 2156922 - 45 CARDS. K-K ACTIVE SUBSTANCE: 1 ML OF SOLUTION CONTAINS 2.5 MG OF LEVOSIMENDAN. DOES NOT CONTAIN VITAMINS, IODINE, ANTIBIOTICS, HORMONES, ALKALOIDS; FOR THERAPEUTIC USE. LABELING IN ACCORDANCE WITH THE LAW OF UKRAINE ""ON MEDICINAL PRODUCTS"". TRADE MARK - ORION PHARMA. MANUFACTURER - ORION CORPORATION, FINLAND. COUNTRY OF MANUFACTURE - FI.""" | |
|
FINLAND | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCT FOR HUMANS PACKAGED FOR RETAIL SALE. DEXDOR, CONCENTRATE FOR SOLUTION FOR INFUSIONS, 100 ΜG/ML, 2 ML IN AN AMPOULE, 5 AMPOULES IN A CARDBOARD BOX, SERIES 2107507 - 500 CARDS. COR-K.DEXDOR, CONCENTRATE FOR SOLUTION FOR INFUSIONS, 100 ΜG/ML, 2 ML IN AN AMPOULE, 5 AMPOULES IN A CARDBOARD BOX, SERIES 2059509 - 100 CARDS. COR-K.DEXDOR, CONCENTRATE FOR SOLUTION FOR INFUSIONS, 100 ΜG/ML, 2 ML IN AN AMPOULE, 5 AMPOULES IN A CARDBOARD BOX, SERIES 2079084 - 50 CARDS. COR-K. ACTIVE (ACTIVE) SUBSTANCE - 1 ML CONTAINS 118 ΜG OF DEXMEDETOMIDINE HYDROCHLORIDE, WHICH IS EQUIVALENT TO 100 ΜG OF DEXMEDETOMIDINE. FOR THERAPEUTIC USE, IT DOES NOT CONTAIN VITAMINS, IODINE, ANTIBIOTICS, HORMONES, ALKALOIDS. LABELING IN ACCORDANCE WITH THE LAW OF UKRAINE ""ON MEDICINAL PRODUCTS"". MANUFACTURER - ORION CORPORATION, FINLAND. TRADE MARK - ORION PHARMA. COUNTRY OF MANUFACTURE - FI.""" | |
|
FINLAND | UKRAINE | 0 |
| 2106909200 | 1. SPECIALIZED DIETARY FOOD PRODUCT (DIETARY SUPPLEMENT). REGIDROSTANDART, POWDER FOR PREPARING A SOLUTION FOR INTERNAL ADMINISTRATION, 10 STICKS (4.36 GRAMS OF POWDER EACH), IN A CARDBOARD PACK, SERIES E04515 - 280 CARDS. PACK. EACH STICK (4.36 G) CONTAINS: ANHYDROUS DEXTROSE - 3.24 G; SODIUM CITRATE DIHYDRATE - 0.59 G; POTASSIUM CHLORIDE - 0.3 G.; SODIUM CHLORIDE - 0.23 G. IT IS A PRODUCT FOR SPECIAL MEDICAL PURPOSES FOR CHILDREN FROM THE FIRST DAYS OF LIFE AND FOR ADULTS. IT IS NOT A MEDICINE. IT DOES NOT CONTAIN ETHYL ALCOHOL. DOES NOT CONTAIN COMPONENTS OF ANIMAL ORIGIN. MARKING MEETS THE REQUIREMENTS OF THE DECREE NO. 771/97-VR DATED 12/23/1997 ""ON BASIC PRINCIPLES AND REQUIREMENTS FOR THE SAFETY AND QUALITY OF FOOD PRODUCTS"". THE MANUFACTURER OF THE FINAL PRODUCT IS FINE FOODS & PHARMACEUTICALS N.T.M. S.P.A., ITALY (FOR ORION CORPORATION, FINLAND). RELEASE INTO CIRCULATION AND RESPONSIBILITY FOR QUALITY - ORION CORPORATION, FINLAND. TRADEMARK - ORION PHARMA. COUNTRY OF MANUFACTURE - IT.""" | |
|
ITALY | UKRAINE | 0 |
| 3004320000 | 1. MEDICINAL PRODUCT FOR HUMANS IN DOSED PACKAGING. METIPRED, POWDER FOR SOLUTION FOR INJECTION, 250 MG EACH, 1 BOTTLE WITH POWDER IN A CARDBOARD BOX, SERIES 2201098.1 - 1000 CARDS. K-K ACTIVE SUBSTANCES: 1 BOTTLE CONTAINS METHYLPREDNISOLONE SODIUM SUCCINATE 331.5 MG, EQUIVALENT TO 250 MG OF METHYLPREDNISOLONE. METHYLPREDNISOLONE IS A SYNTHETIC DRUG FROM THE GROUP OF GLUCOCORTICOID HORMONES. IT CONTAINS HORMONES OF THE ADRENAL CORTEX BUT DOES NOT CONTAIN ANTIBIOTICS; FOR THERAPEUTIC USE. LABELING IN ACCORDANCE WITH THE LAW OF UKRAINE ""ON MEDICINAL PRODUCTS"". TRADE MARK - ORION PHARMA. MANUFACTURERS: THE MANUFACTURER THAT CARRIES OUT PRODUCTION, PACKAGING AND QUALITY CONTROL - HIKMA PHARMACEUTICS (PORTUGAL), S.A., PORTUGAL; THE MANUFACTURER, WHICH CARRIES OUT SECONDARY PACKAGING, QUALITY CONTROL AND SERIES PRODUCTION - ORION CORPORATION, FINLAND. COUNTRY OF MANUFACTURE - FI.""" | |
|
PORTUGAL | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCT FOR HUMANS PACKAGED FOR RETAIL SALE. SIMDAKS, CONCENTRATE FOR PREPARATION OF SOLUTION FOR INFUSIONS, 2.5 MG/ML, 5 ML IN A BOTTLE, 1 BOTTLE IN A CARDBOARD BOX, SERIES 2156922 - 20 CARDS. K-K ACTIVE SUBSTANCE: 1 ML OF SOLUTION CONTAINS 2.5 MG OF LEVOSIMENDAN. DOES NOT CONTAIN VITAMINS, IODINE, ANTIBIOTICS, HORMONES, ALKALOIDS; FOR THERAPEUTIC USE. LABELING IN ACCORDANCE WITH THE LAW OF UKRAINE ""ON MEDICINAL PRODUCTS"". TRADE MARK - ORION PHARMA. MANUFACTURER - ORION CORPORATION, FINLAND. COUNTRY OF MANUFACTURE - FI.""" | |
|
FINLAND | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCT FOR HUMANS PACKAGED FOR RETAIL SALE. SIMDAKS, CONCENTRATE FOR PREPARATION OF SOLUTION FOR INFUSIONS, 2.5 MG/ML, 5 ML IN A BOTTLE, 1 BOTTLE IN A CARDBOARD BOX, SERIES 2147125 - 30 CARDS. K-K ACTIVE SUBSTANCE: 1 ML OF SOLUTION CONTAINS 2.5 MG OF LEVOSIMENDAN. DOES NOT CONTAIN VITAMINS, IODINE, ANTIBIOTICS, HORMONES, ALKALOIDS; FOR THERAPEUTIC USE. LABELING IN ACCORDANCE WITH THE LAW OF UKRAINE ""ON MEDICINAL PRODUCTS"". TRADE MARK - ORION PHARMA. MANUFACTURER - ORION CORPORATION, FINLAND. COUNTRY OF MANUFACTURE - FI.""" | |
|
FINLAND | UKRAINE | 0 |
| 3004390000 | 1. MEDICINAL PRODUCT CONTAINING HORMONES FOR HUMANS, PACKAGED FOR RETAIL SALE. DIVIGEL, GEL 0.1%, 1 G IN A BAG; 28 SACHETS IN A CARDBOARD BOX WITH MARKINGS IN UKRAINIAN AND RUSSIAN, SERIES 2159275 - 1000 CARDS. COR-K. ACTIVE (ACTIVE) SUBSTANCE - 1 SACHET CONTAINS ESTRADIOL HEMIHYDRATE EQUIVALENT TO 1 MG OF ESTRADIOL. ESTRADIOL IS A HORMONE OF THE ESTROGEN GROUP. LABELING ACCORDING TO THE LAW OF UKRAINE ""ON MEDICINAL PRODUCTS"". TRADE MARK - ORION PHARMA. MANUFACTURER - ORION CORPORATION, FINLAND. COUNTRY OF MANUFACTURE - FI.""" | |
|
FINLAND | UKRAINE | 0 |
| 3004390000 | 1. MEDICINAL PRODUCT FOR HUMANS PACKAGED FOR RETAIL SALE. ORGALUTRAN«, SOLUTION FOR INJECTION, 0.5 MG/ML, 0.5 ML IN A PRE-FILLED SYRINGE; 1 SYRINGE TOGETHER WITH A NEEDLE WITH A PROTECTIVE CAP IN AN OPEN PLASTIC TRAY, 5 TRAYS IN A CARDBOARD BOX, SERIES X010006 - 600 CARDS. K-K THE ACTIVE INGREDIENT IS GANIRELIX ACETATE. FOR THERAPEUTIC USE. CONTAINS HORMONES. MARKING IN ACCORDANCE WITH THE LAW OF UKRAINE ""ON MEDICINAL PRODUCTS"". PRODUCTION OF BULK PRODUCTS AND PRIMARY PACKAGING, QUALITY CONTROL - VETTER PHARMA-FERTIGUNG GMBH & CO. KG, GERMANY; SECONDARY PACKAGING, QUALITY CONTROL, PERMISSION TO ISSUE A SERIES - N.V. ORGANON, THE NETHERLANDS.""" | |
|
GERMANY | UKRAINE | 0 |
| 3004390000 | 1. MEDICINAL PRODUCT FOR HUMANS PACKAGED FOR RETAIL SALE. PUREGON«, SOLUTION FOR INJECTION, 833 IU/ML, 0.420 ML (300 IU/0.36 ML) IN A CARTRIDGE; 1 CARTRIDGE IN AN OPEN PLASTIC TRAY COMPLETE WITH NEEDLES, 2 SETS OF NEEDLES - 2 CARTONS (EACH SET OF 3 NEEDLES, EACH NEEDLE IN AN INDIVIDUAL PLASTIC CONTAINER) IN A CARTON, SERIES A102784 - 1500 CARDS. A PACK THE ACTIVE INGREDIENT IS FOLLITROPIN BETA. FOR THERAPEUTIC USE. CONTAINS HORMONES. MARKING IN ACCORDANCE WITH THE LAW OF UKRAINE ""ON MEDICINAL PRODUCTS"". MANUFACTURERS: PRODUCTION OF UNPACKAGED PRODUCTS AND PRIMARY PACKAGING, QUALITY CONTROL, STERILITY AND BACTERIAL ENDOTOXIN TESTING OF THE FINISHED MEDICINAL PRODUCT (QUALITY CONTROL AND STABILITY TESTING), VISUAL INSPECTION - VETTER PHARMA-FERTIGUNG GMBH AND CO. KG, GERMANY; QUALITY CONTROL AND STABILITY TESTING, SECONDARY PACKAGING, APPROVAL FOR SERIES RELEASE - N.V. ORGANON, THE NETHERLANDS.""" | |
|
GERMANY | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCT FOR HUMANS PACKAGED FOR RETAIL SALE. SIMDAKS, CONCENTRATE FOR PREPARATION OF SOLUTION FOR INFUSIONS, 2.5 MG/ML, 5 ML IN A BOTTLE, 1 BOTTLE IN A CARDBOARD BOX, SERIES 2147125 - 33 CARDS. K-K ACTIVE SUBSTANCE: 1 ML OF SOLUTION CONTAINS 2.5 MG OF LEVOSIMENDAN. DOES NOT CONTAIN VITAMINS, IODINE, ANTIBIOTICS, HORMONES, ALKALOIDS; FOR THERAPEUTIC USE. LABELING IN ACCORDANCE WITH THE LAW OF UKRAINE ""ON MEDICINAL PRODUCTS"". TRADE MARK - ORION PHARMA. MANUFACTURER - ORION CORPORATION, FINLAND. COUNTRY OF MANUFACTURE - FI.""" | |
|
FINLAND | UKRAINE | 0 |
| 3004320000 | 1. MEDICINAL PRODUCT FOR HUMANS IN DOSED PACKAGING. METIPRED, POWDER FOR SOLUTION FOR INJECTION, 250 MG EACH, 1 BOTTLE WITH POWDER IN A CARDBOARD BOX, SERIES 2201098.1 - 1000 CARDS. K-K ACTIVE SUBSTANCES: 1 BOTTLE CONTAINS METHYLPREDNISOLONE SODIUM SUCCINATE 331.5 MG, EQUIVALENT TO 250 MG OF METHYLPREDNISOLONE. CONTAINS ADRENAL CORTEX HORMONES BUT WITHOUT ANTIBIOTICS; FOR THERAPEUTIC USE. LABELING IN ACCORDANCE WITH THE LAW OF UKRAINE ""ON MEDICINAL PRODUCTS"". TRADE MARK - ORION PHARMA. MANUFACTURERS: THE MANUFACTURER THAT CARRIES OUT PRODUCTION, PACKAGING AND QUALITY CONTROL - HIKMA PHARMACEUTICS (PORTUGAL), S.A., PORTUGAL; THE MANUFACTURER, WHICH CARRIES OUT SECONDARY PACKAGING, QUALITY CONTROL AND SERIES PRODUCTION - ORION CORPORATION, FINLAND. COUNTRY OF MANUFACTURE - FI.""" | |
|
PORTUGAL | UKRAINE | 0 |
| 3004390000 | 1. HUMAN MEDICINE AS PACKAGED FOR RETAIL SALE. ELONVA, SOLUTION FOR INJECTION 150 MCG/0.5 ML, 0.5 ML SOLUTION IN PRE-FILLED SYRINGE; EACH 1 PRE-FILLED SYRINGE WITH STERILE INJECTION NEEDLE IN OPEN PLASTIC TRAY IN CARDBOARD BOX, SERIES A104177 - 180 CARDS. K-K. ACTIVE INGREDIENT - 1 FILLED SYRINGE (0.5 ML) CONTAINS 150 MCG OF CORIFOLITROPIN ALFA. FOR THERAPEUTIC USE. CONTAINS HORMONES. LABELING IN ACCORDANCE WITH THE LAW OF UKRAINE ""ON MEDICINES"". MANUFACTURERS OF MEDICINAL PRODUCTS:- PRODUCTION OF UNPACKAGED PRODUCTS AND PRIMARY PACKAGING, QUALITY CONTROL, TESTING OF STERILITY AND BACTERIAL ENDOTOXINS OF THE FINISHED LIQUID KARSK REMEDY (QUALITY CONTROL), VISUAL INSPECTION - VETTER PHARMA-FERTIGUNG GMBH I KO. KG, GERMANY;- QUALITY CONTROL AND STABILITY TESTING, SECONDARY PACKAGING, BATCH AUTHORIZATION - N.V. ORGANON, THE NETHERLANDS | |
|
GERMANY | UKRAINE | 0 |
| 3004390000 | 1. HUMAN MEDICINE AS PACKAGED FOR RETAIL SALE. PUREGON®, SOLUTION FOR INJECTION, 833 IU/ML, 0.420 ML (300 IU/0.36ML) IN CARTRIDGE; 1 CARTRIDGE IN OPEN PLASTIC TRAY COMPLETE WITH NEEDLES, 2 SETS OF NEEDLES - 2 CARDBOARD BOXES (EACH SET OF 3 NEEDLES, EACH NEEDLE IN INDIVIDUAL PLASTIC CONTAINER) IN CARDBOARD PACKAGE, SERIES X010867 - 75 6 CARD. PACK ACTIVE INGREDIENT - FOLITROPIN BETA. FOR THERAPEUTIC USE. CONTAINS HORMONES. LABELING IN ACCORDANCE WITH THE LAW OF UKRAINE ""ON MEDICINES"". MANUFACTURERS: PRODUCTION OF UNPACKAGED PRODUCTS AND PRIMARY PACKAGING, QUALITY CONTROL, TESTING OF STERILITY AND BACTERIAL ENDOTOXINS OF THE FINISHED MEDICINAL PRODUCT (CONTRO OL QUALITY AND STABILITY TESTING), VISUAL INSPECTION - VETTER PHARMA-FERTIGUNG GMBH I KO. KG, GERMANY; QUALITY CONTROL AND STABILITY TESTING, SECONDARY PACKAGING, BATCH RELEASE PERMIT - N.V. ORGANON, THE NETHERLANDS | |
|
GERMANY | UKRAINE | 0 |
Get Started with Eximpedia
Start 5 Days Free Trial
No Pay, No Delay - 5 days Your Way!
Book a Free Demo
Learn How our platform works in just 20 minutes!
Download Free Sample Report
Free Import-Export Sample data-One Click Away!
Why should you choose Eximpedia?
Broad Range of Country Datasets
Our dedicated team of experts delivers current and flexible data from key global locations, enabling you to make essential decisions with vital information and insights.
Easy to understand deep analysis
We use bespoke layered visualizations for diving deep into our country and logistics data to provide your team with graphical assistance and essential data analysis and reporting.
Most Accurate Information
All of our datasets are quality-controlled by layers of inspection before it ever reach your platform. This helps us maintain the high reliability our clients have come to trust.
Competitive Supplier Engagement Watch
Keep an eye out for any collaboration between your suppliers and your rivals, as this may impact their ability to satisfy your requirements.
Right away on-screen support
With instant remote on-screen assistance, chat support, and user training, our customer success team is available to you around the clock.
Access Database Across 130+ Countries
Explore competitors' shipment histories, statistical and analytical reports, and country-specific information from more than 130 nations.
Apopharm Llc frequently asked questions
You can explore detailed shipment records of Apopharm Llc through Eximpedia’s real-time trade insights platform, which provides access to shipment dates, quantities, ports, and product details.
Yes, Eximpedia offers a directory of buyers with similar trade patterns to Apopharm Llc. Use advanced filters to identify competitors or partners in the same industry.
With our data-driven platform, you can access a curated list of suppliers with comparable product categories and shipment volumes to Apopharm Llc, helping you expand your sourcing network.
Eximpedia’s trade data highlights Apopharm Llc’s major exports, along with their trade destinations and origins.
We provide detailed analytics, including trade volumes, market trends, port usage, and competitor insights, to help businesses understand Apopharm Llc’s trade activities.
Traders can collaborate with Apopharm Llc by contacting them through their official channels or visiting their headquarters for detailed trade discussions.